Free Trial
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel
NYSE:DVA

DaVita Q3 2026 Earnings Date & Estimates

DaVita logo
$178.97 +1.95 (+1.10%)
Closing price 10/9/2026 03:59 PM Eastern
Extended Trading
$179.10 +0.13 (+0.07%)
As of 10/9/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DaVita is scheduled to report Q3 2026 earnings on Wednesday, October 28, 2026, after market closes. The conference call is scheduled for 5:00 PM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
5:00 PM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from DaVita in Q3 2026

DaVita is expected to post earnings of $3.57 per share on revenue of $3.52 billion. In the same quarter a year earlier DaVita reported $2.51 per share on revenue of $3.42 billion. DaVita last reported on August 4, 2026, posting $4.02 per share and beating the $3.88 consensus estimate. DaVita has beaten the consensus EPS estimate in 6 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$3.57
Expected Revenue
$3.52 billion
Prior-Year EPS
$2.51
Prior-Year Revenue
$3.42 billion
Expected EPS Growth
+42.2%
Expected Revenue Growth
+2.8%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$4.02 (Beat by +$0.14)
Last Quarter Revenue
$3.55 billion
EPS Beat Rate
6 of last 8 quarters

Prepare for the Q3 2026 Call

DaVita Q3 2026 Earnings FAQ

DaVita (NYSE:DVA) is scheduled to report Q3 2026 earnings on Wednesday, October 28, 2026, after market closes.

DaVita's Q3 2026 earnings conference call is scheduled for Wednesday, October 28, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect DaVita to post earnings of $3.57 per share for Q3 2026.

The consensus revenue estimate for DaVita is $3.52 billion for Q3 2026.

DaVita Earnings Headlines

DaVita: After A 25% Drop, The Buyback Machine Is Cheap Again
October 9 at 3:48 PM  |  seekingalpha.comhttps://seekingalpha.com/article/4953153-davita-after-a-25-percent-drop-the-buyback-machine-is-cheap-again
DaVita Activates Emergency Response Efforts Ahead of Hurricane Isaias, Urges Kidney Patients to Prepare Early
October 8 at 4:00 PM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/davita-activates-emergency-response-efforts-ahead-of-hurricane-isaias-urges-kidney-patients-to-prepare-early-302902930.html
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
October 11 at 1:00 AM  |  Weiss Ratings (Ad)
Analyzing SBC Medical Group (NASDAQ:SBC) & DaVita (NYSE:DVA)
October 3, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31082606
DaVita (DVA) Stock May Be Undervalued On Its Earnings Power
September 29, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/davita-dva-stock-may-undervalued-190715338.html
DaVita (DVA)
September 26, 2026  |  es.investing.comhttps://es.investing.com/equities/davita-inc
See More DaVita Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like DaVita? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DaVita and other key companies, straight to your email.

About DaVita

DaVita (NYSE:DVA) is a healthcare company focused on kidney care and renal disease management. Through its DaVita Kidney Care business, the company provides outpatient dialysis treatments for people with end-stage kidney disease, including hemodialysis and peritoneal dialysis, as well as home dialysis support.

The company also operates hospital-based dialysis programs and offers clinical, administrative and care-coordination services intended to support patients across the kidney-care journey. Its services include education, access to care, laboratory support and assistance for patients who may be candidates for kidney transplantation.

DaVita was founded in 1994 as Total Renal Care Holdings and adopted the DaVita name in 2000. Headquartered in Denver, Colorado, the company primarily serves patients in the United States and also has kidney-care operations in selected international markets.

View DaVita Profile
Earnings Tools